Genetically Engineered Mouse-Derived Allograft for Preclinical Studies of Metastatic Melanoma

therapoid

  1. Home
  2. Technologies
  3. Genetically Engineered Mouse-Derived Allograft for Preclinical Studies of Metastatic Melanoma
  4. Summary
Provided by: National Institutes of Health (NIH)
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
Short Description:

This technology pertains to an allograft that resembles human-like melanoma and has features that will stimulate a normal immunological response in the mouse.

Projects based on this Technology

Start New Project